AT223424T - Quinazolinone-connections - Google Patents

Quinazolinone-connections

Info

Publication number
AT223424T
AT223424T AT98902115T AT98902115T AT223424T AT 223424 T AT223424 T AT 223424T AT 98902115 T AT98902115 T AT 98902115T AT 98902115 T AT98902115 T AT 98902115T AT 223424 T AT223424 T AT 223424T
Authority
AT
Austria
Prior art keywords
quinazolinone
connections
Prior art date
Application number
AT98902115T
Other languages
German (de)
Inventor
Roger John Griffin
Alan Hilary Calvert
Nicola Jane Curtin
David Richard Newell
Bernard Thomas Golding
Original Assignee
Univ Newcastle Ventures Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to GBGB9702701.5A priority Critical patent/GB9702701D0/en
Application filed by Univ Newcastle Ventures Ltd filed Critical Univ Newcastle Ventures Ltd
Priority to PCT/GB1998/000303 priority patent/WO1998033802A1/en
Publication of AT223424T publication Critical patent/AT223424T/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/86Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 4
    • C07D239/88Oxygen atoms
    • C07D239/91Oxygen atoms with aryl or aralkyl radicals attached in positions 2 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00Compounds containing elements of Groups 5 or 15 of the Periodic System
    • C07F9/02Phosphorus compounds
    • C07F9/547Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
    • C07F9/645Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having two nitrogen atoms as the only ring hetero atoms
    • C07F9/6509Six-membered rings
    • C07F9/6512Six-membered rings having the nitrogen atoms in positions 1 and 3
    • C07F9/65128Six-membered rings having the nitrogen atoms in positions 1 and 3 condensed with carbocyclic rings or carbocyclic ring systems
AT98902115T 1997-02-01 1998-01-30 Quinazolinone-connections AT223424T (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB9702701.5A GB9702701D0 (en) 1997-02-01 1997-02-01 Quinazolinone compounds
PCT/GB1998/000303 WO1998033802A1 (en) 1997-02-01 1998-01-30 Quinazolinone compounds

Publications (1)

Publication Number Publication Date
AT223424T true AT223424T (en) 2002-09-15

Family

ID=10807378

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98902115T AT223424T (en) 1997-02-01 1998-01-30 Quinazolinone-connections

Country Status (10)

Country Link
US (1) US6156739A (en)
EP (1) EP0966476B1 (en)
JP (1) JP2001511776A (en)
KR (1) KR20000070467A (en)
AT (1) AT223424T (en)
AU (1) AU5873998A (en)
CA (1) CA2278290C (en)
DE (1) DE69807661D1 (en)
GB (1) GB9702701D0 (en)
WO (1) WO1998033802A1 (en)

Families Citing this family (65)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1184208C (en) 1998-11-27 2005-01-12 巴斯福股份公司 Substituted benzimidazoles and their prepn. and use
CN100418967C (en) 1999-01-11 2008-09-17 阿古龙制药公司;癌症研究推广技术有限公司 Tricyclic inhibitors of poly(ADP-ribose) polymerases
AU2004200A (en) * 1999-01-14 2000-08-01 Meiji Seika Kaisha Ltd. Poly(adp-ribose) polymerase inhibitors consisting of pyrimidine derivatives
DE19916460B4 (en) * 1999-04-12 2006-12-21 Abbott Gmbh & Co. Kg Substituted benzimidazoles, their preparation and use
DE19918211A1 (en) 1999-04-22 2000-10-26 Basf Ag New 2-carbocyclyl-benzimidazole-carboxamide derivatives, are PARP inhibitors useful e.g. for treating neurodegenerative disease, epilepsy, ischemia, tumors, inflammation or diabetes
ECSP003637A (en) 1999-08-31 2002-03-25 Agouron Pharma Tricyclic inhibitors of poly (adp-ribose) polymerases
NZ521792A (en) * 2000-03-20 2004-06-25 N Gene Res Lab Inc Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and use in treating conditions connected with oxygen deficiency
AU4689301A (en) * 2000-04-18 2001-10-30 Sumitomo Pharma Tricyclic quinazolinediones
US6667300B2 (en) 2000-04-25 2003-12-23 Icos Corporation Inhibitors of human phosphatidylinositol 3-kinase delta
US7514067B2 (en) 2000-04-25 2009-04-07 President And Fellows Of Harvard College Methods for tumor diagnosis and therapy
EP1278748B1 (en) * 2000-04-25 2011-03-23 ICOS Corporation Inhibitors of human phosphatidyl-inositol 3-kinase delta
DE10034801A1 (en) * 2000-07-18 2002-01-31 Bayer Ag Substituted amidoalkyl uracils and their use
WO2002044157A2 (en) * 2000-12-01 2002-06-06 Iconix Pharmaceuticals, Inc. Parb inhibitors
AUPR201600A0 (en) * 2000-12-11 2001-01-11 Fujisawa Pharmaceutical Co., Ltd. Quinazolinone derivative
AUPS019702A0 (en) * 2002-01-29 2002-02-21 Fujisawa Pharmaceutical Co., Ltd. Condensed heterocyclic compounds
ES2440217T3 (en) * 2002-10-04 2014-01-28 Prana Biotechnology Limited Neurologically active compounds
CA2505876A1 (en) * 2002-11-12 2004-05-27 Mochida Pharmaceutical Co., Ltd. Novel parp inhibitors
JP4887139B2 (en) 2003-03-25 2012-02-29 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
US7638638B2 (en) 2003-05-14 2009-12-29 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7678909B1 (en) 2003-08-13 2010-03-16 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US20050065148A1 (en) 2003-08-13 2005-03-24 Syrrx, Inc. Dipeptidyl peptidase inhibitors
US7169926B1 (en) 2003-08-13 2007-01-30 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7790734B2 (en) 2003-09-08 2010-09-07 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US7732446B1 (en) 2004-03-11 2010-06-08 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
CN102079743A (en) 2004-03-15 2011-06-01 武田药品工业株式会社 Dipeptidyl peptidase inhibitors
HUE030839T2 (en) 2004-05-13 2017-06-28 Icos Corp Quinazolinones as inhibitors of human phosphatidylinositol 3-kinase delta
JP2008501714A (en) 2004-06-04 2008-01-24 武田薬品工業株式会社 Dipeptidyl peptidase inhibitor
WO2006019965A2 (en) 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
US7872124B2 (en) 2004-12-21 2011-01-18 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
MX2007008771A (en) 2005-01-19 2007-09-11 Mgi Gp Inc Diazabenzo[de]anthracen-3-one compounds and methods for inhibiting parp.
CA2615374A1 (en) 2005-07-18 2007-01-25 Ernest Kun Kun Treatment of cancer
KR20190054186A (en) * 2006-09-13 2019-05-21 다케다 야쿠힌 고교 가부시키가이샤 Use of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2h-pyrimidin-1-ylmethyl]-4-fluoro-benzonitrile
RS52110B2 (en) 2005-09-14 2018-05-31 Takeda Pharmaceuticals Co Dipeptidyl peptidase inhibitors for treating diabetes
US8222411B2 (en) 2005-09-16 2012-07-17 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
US8324383B2 (en) 2006-09-13 2012-12-04 Takeda Pharmaceutical Company Limited Methods of making polymorphs of benzoate salt of 2-[[6-[(3R)-3-amino-1-piperidinyl]-3,4-dihydro-3-methyl-2,4-dioxo-1(2H)-pyrimidinyl]methyl]-benzonitrile
EP1948215B1 (en) 2005-11-14 2012-01-11 Centre National De La Recherche Scientifique (Cnrs) MacroH2A non-histone domain as inhibitor of PARP-1 activity and uses thereof
WO2007112347A1 (en) 2006-03-28 2007-10-04 Takeda Pharmaceutical Company Limited Dipeptidyl peptidase inhibitors
NZ590271A (en) 2006-04-14 2011-12-22 Prana Biotechnology Ltd 9-hydroxy-3-substituted-4H-pyrido[1,2-a]pyrimidin-4-ones and 9-hydroxy-3-substituted-4H-pyrido[1,2-a]pyrimidin-4-thiones
US20070259937A1 (en) 2006-05-02 2007-11-08 Giranda Vincent L Substituted 1h-benzimidazole-4-carboxamides are potent parp inhibitors
EP2059498A4 (en) 2006-09-05 2011-01-12 Bipar Sciences Inc Treatment of cancer
CN102379884A (en) 2006-09-05 2012-03-21 彼帕科学公司 Inhibition of fatty acid synthesis by PARP inhibitors and methods of treatment thereof
US20080262062A1 (en) * 2006-11-20 2008-10-23 Bipar Sciences, Inc. Method of treating diseases with parp inhibitors
TW200838536A (en) 2006-11-29 2008-10-01 Takeda Pharmaceutical Polymorphs of succinate salt of 2-[6-(3-amino-piperidin-1-yl)-3-methyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethy]-4-fluor-benzonitrile and methods of use therefor
US8093236B2 (en) 2007-03-13 2012-01-10 Takeda Pharmaceuticals Company Limited Weekly administration of dipeptidyl peptidase inhibitors
KR101596526B1 (en) 2007-10-03 2016-02-22 에이자이 아이엔씨. Parp inhibitor compounds, compositions and methods of use
RU2480211C2 (en) 2007-11-12 2013-04-27 Байпар Сайенсиз, Инк. Method of treating breast cancer with compound of 4-iodine-3-nitrobenzamine in combination with anticancer agents
CN101531638B (en) * 2008-03-13 2011-12-28 中国科学院广州生物医药与健康研究院 As estrogen-related receptor modulator compounds and uses thereof
CN101628913B (en) 2008-07-18 2013-01-23 中国科学院广州生物医药与健康研究院 Compound as estrogen-related receptor modulator and application thereof
US20100202963A1 (en) 2008-11-13 2010-08-12 Gallatin W Michael Therapies for hematologic malignancies
US9492449B2 (en) 2008-11-13 2016-11-15 Gilead Calistoga Llc Therapies for hematologic malignancies
EP2411391A1 (en) 2009-03-24 2012-02-01 Gilead Calistoga LLC Atropisomers of2-purinyl-3-tolyl-quinazolinone derivatives and methods of use
WO2011011550A1 (en) 2009-07-21 2011-01-27 Calistoga Pharmaceuticals Inc. Treatment of liver disorders with pi3k inhibitors
ES2587657T3 (en) 2010-09-03 2016-10-26 Bayer Intellectual Property Gmbh Substituted condensed dihydropyrimidinone derivatives
US8999985B2 (en) 2010-12-02 2015-04-07 Shanghai De Novo Pharmatech Co Ltd. Substituted phthalazin-1(2H)-ones, preparation processes and medical uses thereof
GB2501403B (en) * 2011-02-15 2018-02-21 Council Of Scient And Industrial Research 3-arylethynyl substituted quinazolinone compounds
US9617274B1 (en) 2011-08-26 2017-04-11 Demerx, Inc. Synthetic noribogaine
EP2788003A4 (en) * 2011-12-09 2015-05-27 Demerx Inc Phosphate esters of noribogaine
EP2834241A4 (en) 2012-03-05 2015-11-11 Gilead Calistoga Llc Polymorphic forms of (s)-2-(1-(9h-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin-4(3h)-one
CN104662006B (en) * 2012-09-26 2017-10-24 默克专利股份公司 It is used as the Quinzolone derivatives of PARP inhibitor
WO2014087165A1 (en) * 2012-12-06 2014-06-12 University Of Bath Tankyrase inhibitors
EP2934541A4 (en) 2012-12-20 2016-08-03 Demerx Inc Substituted noribogaine
EP3083630B1 (en) 2013-12-20 2019-08-21 Gilead Calistoga LLC Process methods for phosphatidylinositol 3-kinase inhibitors
AU2014364414A1 (en) 2013-12-20 2016-06-30 Gilead Calistoga Llc Polymorphic forms of a hydrochloride salt of (S) -2-(1-(9H-purin-6-ylamino) propyl) -5-fluoro-3-phenylquinazolin-4 (3H) -one
US20190269655A1 (en) 2016-07-28 2019-09-05 Mitobridge, Inc. Methods of treating acute kidney injury
KR20190107656A (en) 2016-11-02 2019-09-20 이뮤노젠 아이엔씨 Combination treatment with antibody-drug conjugates and PARP inhibitors

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995024410A1 (en) * 1994-03-08 1995-09-14 Otsuka Pharmaceutical Factory, Inc. Phosphonic diester derivative
GB9404485D0 (en) * 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues

Also Published As

Publication number Publication date
US6156739A (en) 2000-12-05
JP2001511776A (en) 2001-08-14
EP0966476A1 (en) 1999-12-29
EP0966476B1 (en) 2002-09-04
WO1998033802A1 (en) 1998-08-06
CA2278290A1 (en) 1998-08-06
CA2278290C (en) 2005-05-10
AU5873998A (en) 1998-08-25
KR20000070467A (en) 2000-11-25
GB9702701D0 (en) 1997-04-02
DE69807661D1 (en) 2002-10-10

Similar Documents

Publication Publication Date Title
AT249813T (en) Einhüllungssverfahren
AT248812T (en) Arylsulfonylhydroxamsäurederivate
AT200030T (en) Pegylationsverfahren
AT215714T (en) Anitivirenbeschleuniger
AT267801T (en) N-alkanoylphenylalaninderivate
DE29719526U1 (en) Neurotrokar
AT279163T (en) Gewebedezellularization
AT213265T (en) Fluorezentes guest-host-system
AT260243T (en) N-aroylphenylalaninderivate
AT223424T (en) Quinazolinone-connections
AT260538T (en) Niederspannungsbeleuchtungsvorrichung
AT281859T (en) Inhalatormechanismus
ATA93198A (en) Fluoxetinpellets
DE19882665T1 (en) Tilt-and-go Losträgerinterfacejustiersystem
DE29714185U1 (en) Funkarmbanduhr
AT202994T (en) Isoliertransportbehälter
AT258745T (en) Saatkeimungträger
AT202675T (en) Nährungserganzungmittel
AT279450T (en) Olefinenpolymerisation
AT250285T (en) Umwandleranschlussbuchse
AT244032T (en) Einmalinhalator
AT255248T (en) Prozessueberwachungsvorrichtung
AT233247T (en) Phtalazinonen
AT238984T (en) Sulfonylaminocarbonsäuren
AT239957T (en) Kartenausgagekassette

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties